-
1
-
-
66349098682
-
Update of the LIPID MAPS comprehensive classifi- cation system for lipids
-
Fahy, E., S. Subramaniam, R. C. Murphy, M. Nishijima, C. R. Raetz, T. Shimizu, F. Spener, G. van Meer, M. J. Wakelam, and E. A. Dennis. 2009. Update of the LIPID MAPS comprehensive classifi- cation system for lipids. J. Lipid Res. 50 (Suppl.) : S9 - S14.
-
(2009)
J. Lipid Res
, vol.50
, Issue.SUPPL.
-
-
Fahy, E.1
Subramaniam, S.2
Murphy, R.C.3
Nishijima, M.4
Raetz, C.R.5
Shimizu, T.6
Spener, F.7
Van Meer, G.8
Wakelam, M.J.9
Dennis, E.A.10
-
2
-
-
58149308844
-
Altered lipid metabolism in brain injury and disorders
-
Adibhatla, R. M., and J. F. Hatcher. 2008. Altered lipid metabolism in brain injury and disorders. Subcell. Biochem. 49: 241-268.
-
(2008)
Subcell. Biochem
, vol.49
, pp. 241-268
-
-
Adibhatla, R.M.1
Hatcher, J.F.2
-
3
-
-
23444444518
-
Lipid signaling in neural plasticity, brain repair, and neuroprotection
-
Bazan, N. G. 2005. Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32: 89-103.
-
(2005)
Mol. Neurobiol
, vol.32
, pp. 89-103
-
-
Bazan, N.G.1
-
4
-
-
29244490349
-
Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods
-
Fonteh, A. N., R. J. Harrington, A. F. Huhmer, R. G. Biringer, J. N. Riggins, and M. G. Harrington. 2006. Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods. Dis. Markers. 22: 39-64.
-
(2006)
Dis. Markers
, vol.22
, pp. 39-64
-
-
Fonteh, A.N.1
Harrington, R.J.2
Huhmer, A.F.3
Biringer, R.G.4
Riggins, J.N.5
Harrington, M.G.6
-
6
-
-
0034912915
-
In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling
-
Rapoport, S. I. 2001. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. J. Mol. Neurosci. 16: 243-261.
-
(2001)
J. Mol. Neurosci
, vol.16
, pp. 243-261
-
-
Rapoport, S.I.1
-
7
-
-
0023880543
-
Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A 2
-
Kramer, R. M., J. A. Jakubowski, and D. Deykin. 1988. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A 2. Biochim. Biophys. Acta. 959: 269-279.
-
(1988)
Biochim. Biophys. Acta
, vol.959
, pp. 269-279
-
-
Kramer, R.M.1
Jakubowski, J.A.2
Deykin, D.3
-
8
-
-
3142646870
-
Brain phospholipases A 2: A perspective on the history. Prostaglandins Leukot. Essent
-
Farooqui, A. A., and L. A. Horrocks. 2004. Brain phospholipases A 2: a perspective on the history. Prostaglandins Leukot. Essent. Fatty Acids. 71: 161-169.
-
(2004)
Fatty Acids
, vol.71
, pp. 161-169
-
-
Farooqui, A.A.1
Horrocks, L.A.2
-
9
-
-
0034739463
-
The expanding superfamily of phospholipase A (2) enzymes: Classification and characterization
-
Six, D. A., and E. A. Dennis. 2000. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta. 1488: 1-19.
-
(2000)
Biochim. Biophys. Acta
, vol.1488
, pp. 1-19
-
-
Six, D.A.1
Dennis, E.A.2
-
10
-
-
0032953013
-
Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation
-
Khaselev, N., and R. C. Murphy. 1999. Susceptibility of plasmenyl glycerophosphoethanolamine lipids containing arachidonate to oxidative degradation. Free Radic. Biol. Med. 26: 275-284.
-
(1999)
Free Radic. Biol. Med
, vol.26
, pp. 275-284
-
-
Khaselev, N.1
Murphy, R.C.2
-
11
-
-
0034672281
-
Lecithin cholesterol acyltransferase
-
Jonas, A. 2000. Lecithin cholesterol acyltransferase. Molecular and Cell Biology of Lipids. 1529: 245-256.
-
(2000)
Molecular and Cell Biology of Lipids
, vol.1529
, pp. 245-256
-
-
Jonas, A.1
-
13
-
-
33847702499
-
Critical enzymes involved in endocannabinoid metabolism
-
Basavarajappa, B. S. 2007. Critical enzymes involved in endocannabinoid metabolism. Protein Pept. Lett. 14: 237-246.
-
(2007)
Protein Pept. Lett
, vol.14
, pp. 237-246
-
-
Basavarajappa, B.S.1
-
14
-
-
0034212295
-
The endocannabinoid system as a target for therapeutic drugs
-
Piomelli, D., A. Giuffrida, A. Calignano, and F. F. Rodriguez De. 2000. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci. 21: 218-224.
-
(2000)
Trends Pharmacol. Sci
, vol.21
, pp. 218-224
-
-
Piomelli, D.1
Giuffrida, A.2
Calignano, A.3
De Rodriguez, F.F.4
-
15
-
-
69549128249
-
Biology of endocannabinoid synthesis system
-
Wang, J., and N. Ueda. 2009. Biology of endocannabinoid synthesis system. Prostaglandins Other Lipid Mediat. 89: 112-119.
-
(2009)
Prostaglandins Other Lipid Mediat
, vol.89
, pp. 112-119
-
-
Wang, J.1
Ueda, N.2
-
16
-
-
0034618030
-
Phospholipid signaling in apoptosis: Peroxidation and externalization of phosphatidylserine
-
Tyurina, Y. Y., A. Shvedova, K. Kawai, V. A. Tyurin, C. Kommineni, P. Quinn, N. Schor, J. Fabisiak, and V. Kagan. 2000. Phospholipid signaling in apoptosis: peroxidation and externalization of phosphatidylserine. Toxicology. 148: 93-101.
-
(2000)
Toxicology
, vol.148
, pp. 93-101
-
-
Tyurina, Y.Y.1
Shvedova, A.2
Kawai, K.3
Tyurin, V.A.4
Kommineni, C.5
Quinn, P.6
Schor, N.7
Fabisiak, J.8
Kagan, V.9
-
17
-
-
0023824378
-
Neurochemical aspects of Alzheimer's disease: Involvement of membrane phospholipids
-
Farooqui, A. A., L. Liss, and L. A. Horrocks. 1988. Neurochemical aspects of Alzheimer's disease: involvement of membrane phospholipids. Metab. Brain Dis. 3: 19-35.
-
(1988)
Metab. Brain Dis
, vol.3
, pp. 19-35
-
-
Farooqui, A.A.1
Liss, L.2
Horrocks, L.A.3
-
18
-
-
84878491154
-
Phospholipids and Alzheimer's disease: Alterations, mechanisms and potential biomarkers
-
Kosicek, M., and S. Hecimovic. 2013. Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers. Int. J. Mol. Sci. 14: 1310-1322.
-
(2013)
Int. J. Mol. Sci
, vol.14
, pp. 1310-1322
-
-
Kosicek, M.1
Hecimovic, S.2
-
19
-
-
0025913434
-
Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease
-
Söderberg, M., C. Edlund, K. Kristensson, and G. Dallner. 1991. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids. 26: 421-425.
-
(1991)
Lipids
, vol.26
, pp. 421-425
-
-
Söderberg, M.1
Edlund, C.2
Kristensson, K.3
Dallner, G.4
-
20
-
-
0031778148
-
Plasmalogen-selective phospholipase A 2 and its involvement in Alzheimer's disease
-
Farooqui, A. A., and L. A. Horrocks. 1998. Plasmalogen-selective phospholipase A 2 and its involvement in Alzheimer's disease. Biochem. Soc. Trans. 26: 243-246.
-
(1998)
Biochem. Soc. Trans
, vol.26
, pp. 243-246
-
-
Farooqui, A.A.1
Horrocks, L.A.2
-
21
-
-
1942436711
-
Platelet phospholipase A 2 activity in Alzheimer's disease and mild cognitive impairment
-
Gattaz, W. F., O. V. Forlenza, L. L. Talib, N. R. Barbosa, and C. M. Bottino. 2004. Platelet phospholipase A 2 activity in Alzheimer's disease and mild cognitive impairment. J. Neural Transm. 111: 591-601.
-
(2004)
J. Neural Transm
, vol.111
, pp. 591-601
-
-
Gattaz, W.F.1
Forlenza, O.V.2
Talib, L.L.3
Barbosa, N.R.4
Bottino, C.M.5
-
22
-
-
0031937355
-
Phospholipid-metabolizing enzymes in Alzheimer's disease: Increased lysophospholipid acyltransferase activity and decreased phospholipase A 2 activity
-
Ross, B. M., A. Moszczynska, J. Erlich, and S. J. Kish. 1998. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A 2 activity. J. Neurochem. 70: 786-793.
-
(1998)
J. Neurochem
, vol.70
, pp. 786-793
-
-
Ross, B.M.1
Moszczynska, A.2
Erlich, J.3
Kish, S.J.4
-
23
-
-
0029657725
-
Cytosolic phospholipase A 2 (cPLA 2) immunoreactivity is elevated in Alzheimer's disease brain
-
Stephenson, D. T., C. A. Lemere, D. J. Selkoe, and J. A. Clemens. 1996. Cytosolic phospholipase A 2 (cPLA 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol. Dis. 3: 51-63.
-
(1996)
Neurobiol. Dis
, vol.3
, pp. 51-63
-
-
Stephenson, D.T.1
Lemere, C.A.2
Selkoe, D.J.3
Clemens, J.A.4
-
24
-
-
76749115747
-
The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid
-
Harrington, M. G., A. N. Fonteh, E. Oborina, P. Liao, R. P. Cowan, G. McComb, J. N. Chavez, J. Rush, R. G. Biringer, and A. F. Huhmer. 2009. The morphology and biochemistry of nanostructures provide evidence for synthesis and signaling functions in human cerebrospinal fluid. Cerebrospinal Fluid Res. 6: 10.
-
(2009)
Cerebrospinal Fluid Res
, vol.6
, pp. 10
-
-
Harrington, M.G.1
Fonteh, A.N.2
Oborina, E.3
Liao, P.4
Cowan, R.P.5
McComb, G.6
Chavez, J.N.7
Rush, J.8
Biringer, R.G.9
Huhmer, A.F.10
-
25
-
-
79956142378
-
The diagnosis of dementia due to Alzheimer's disease: Recommendation from the National Institute on Aging Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
McKhann, G. M., D. S. Knopman, H. Chertkow, B. T. Hyman, C. R. Jack, Jr., C. H. Kawas, W. E. Klunk, W. J. Koroshetz, J. J. Manly, R. Mayeux, et al. 2011. The diagnosis of dementia due to Alzheimer's disease: recommendation from the National Institute on Aging Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 77: 263-269.
-
(2011)
Alzheimer's Dement
, vol.77
, pp. 263-269
-
-
McKhann, G.M.1
Knopman, D.S.2
Chertkow, H.3
Hyman, B.T.4
Jack Jr., C.R.5
Kawas, C.H.6
Klunk, W.E.7
Koroshetz, W.J.8
Manly, J.J.9
Mayeux, R.10
-
26
-
-
0031438475
-
Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type
-
Morris, J. C. 1997. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 9 (Suppl. 1) : 173-176.
-
(1997)
Int. Psychogeriatr
, vol.9
, Issue.SUPPL. 1
, pp. 173-176
-
-
Morris, J.C.1
-
27
-
-
4544335597
-
Mild cognitive impairment as a diagnostic entity
-
Petersen, R. C. 2004. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256: 183-194.
-
(2004)
J. Intern. Med
, vol.256
, pp. 183-194
-
-
Petersen, R.C.1
-
28
-
-
33845261493
-
A rapid method of total lipid extraction and purification
-
Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
-
(1959)
Can. J. Biochem. Physiol
, vol.37
, pp. 911-917
-
-
Bligh, E.G.1
Dyer, W.J.2
-
30
-
-
0033950917
-
Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques
-
Harrison, K. A., S. S. Davies, G. K. Marathe, T. McIntyre, S. Prescott, K. M. Reddy, J. R. Falck, and R. C. Murphy. 2000. Analysis of oxidized glycerophosphocholine lipids using electrospray ionization mass spectrometry and microderivatization techniques. J. Mass Spectrom. 35: 224-236.
-
(2000)
J. Mass Spectrom
, vol.35
, pp. 224-236
-
-
Harrison, K.A.1
Davies, S.S.2
Marathe, G.K.3
McIntyre, T.4
Prescott, S.5
Reddy, K.M.6
Falck, J.R.7
Murphy, R.C.8
-
31
-
-
0035181804
-
Oxidized LDL contains inflammatory PAF-like phospholipids
-
Marathe, G. K., S. M. Prescott, G. A. Zimmerman, and T. M. McIntyre. 2001. Oxidized LDL contains inflammatory PAF-like phospholipids. Trends Cardiovasc. Med. 11: 139-142.
-
(2001)
Trends Cardiovasc. Med
, vol.11
, pp. 139-142
-
-
Marathe, G.K.1
Prescott, S.M.2
Zimmerman, G.A.3
McIntyre, T.M.4
-
32
-
-
0027971009
-
A continuous fluorescence-based assay for the human high-molecular- weight cytosolic phospholipase A 2
-
Huang, Z., F. Laliberte, N. M. Tremblay, P. K. Weech, and I. P. Street. 1994. A continuous fluorescence-based assay for the human high-molecular- weight cytosolic phospholipase A 2. Anal. Biochem. 222: 110-115.
-
(1994)
Anal. Biochem
, vol.222
, pp. 110-115
-
-
Huang, Z.1
Laliberte, F.2
Tremblay, N.M.3
Weech, P.K.4
Street, I.P.5
-
33
-
-
29244469691
-
Protein analysis in human cerebrospinal fluid: Physiological aspects, current progress and future challenges
-
Huhmer, A. F., R. G. Biringer, H. Amato, A. N. Fonteh, and M. G. Harrington. 2006. Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and future challenges. Dis. Markers. 22: 3-26.
-
(2006)
Dis. Markers
, vol.22
, pp. 3-26
-
-
Huhmer, A.F.1
Biringer, R.G.2
Amato, H.3
Fonteh, A.N.4
Harrington, M.G.5
-
34
-
-
18344393519
-
Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples
-
Han, X., and R. W. Gross. 2005. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom. Rev. 24: 367-412.
-
(2005)
Mass Spectrom. Rev
, vol.24
, pp. 367-412
-
-
Han, X.1
Gross, R.W.2
-
35
-
-
33746297150
-
Lipidomics: An analysis of cellular lipids by ESI-MS
-
Milne, S., P. Ivanova, J. Forrester, and B. H. Alex. 2006. Lipidomics: an analysis of cellular lipids by ESI-MS. Methods. 39: 92-103.
-
(2006)
Methods
, vol.39
, pp. 92-103
-
-
Milne, S.1
Ivanova, P.2
Forrester, J.3
Alex, B.H.4
-
36
-
-
79960366538
-
Measurement of phospholipids by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry: The determination of choline containing compounds in foods
-
Zhao, Y. Y., Y. Xiong, and J. M. Curtis. 2011. Measurement of phospholipids by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry: the determination of choline containing compounds in foods. J. Chromatogr. A. 1218: 5470-5479.
-
(2011)
J. Chromatogr. A.
, vol.1218
, pp. 5470-5479
-
-
Zhao, Y.Y.1
Xiong, Y.2
Curtis, J.M.3
-
37
-
-
84863989944
-
Chemistry of phospholipid oxidation
-
Reis, A., and C. M. Spickett. 2012. Chemistry of phospholipid oxidation. Biochim. Biophys. Acta. 1818: 2374-2387.
-
(2012)
Biochim. Biophys. Acta
, vol.1818
, pp. 2374-2387
-
-
Reis, A.1
Spickett, C.M.2
-
38
-
-
84873107757
-
N-acylation of phosphatidylethanolamine and its biological functions in mammals
-
Wellner, N., T. A. Diep, C. Janfelt, and H. S. Hansen. 2013. N-acylation of phosphatidylethanolamine and its biological functions in mammals. Biochim. Biophys. Acta. 1831: 652-662.
-
(2013)
Biochim. Biophys. Acta
, vol.1831
, pp. 652-662
-
-
Wellner, N.1
Diep, T.A.2
Janfelt, C.3
Hansen, H.S.4
-
39
-
-
77957944897
-
Enzymological studies on the biosynthesis of N-acylethanolamines
-
Ueda, N., K. Tsuboi, and T. Uyama. 2010. Enzymological studies on the biosynthesis of N-acylethanolamines. Biochim. Biophys. Acta. 1801: 1274-1285.
-
(2010)
Biochim. Biophys. Acta
, vol.1801
, pp. 1274-1285
-
-
Ueda, N.1
Tsuboi, K.2
Uyama, T.3
-
40
-
-
33748743637
-
Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway
-
Simon, G. M., and B. F. Cravatt. 2006. Endocannabinoid biosynthesis proceeding through glycerophospho-N-acyl ethanolamine and a role for alpha/beta-hydrolase 4 in this pathway. J. Biol. Chem. 281: 26465-26472.
-
(2006)
J. Biol. Chem
, vol.281
, pp. 26465-26472
-
-
Simon, G.M.1
Cravatt, B.F.2
-
41
-
-
84870500488
-
Plasma lipoprotein-associated phospholipase A 2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: A cross-sectional study
-
Davidson, J. E., A. Lockhart, L. Amos, H. A. Stirnadel-Farrant, V. Mooser, M. Sollberger, A. Regeniter, A. U. Monsch, and M. C. Irizarry. 2012. Plasma lipoprotein-associated phospholipase A 2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study. Alzheimers Res. Ther. 4: 51.
-
(2012)
Alzheimers Res. Ther
, vol.4
, pp. 51
-
-
Davidson, J.E.1
Lockhart, A.2
Amos, L.3
Stirnadel-Farrant, H.A.4
Mooser, V.5
Sollberger, M.6
Regeniter, A.7
Monsch, A.U.8
Irizarry, M.C.9
-
42
-
-
77955278673
-
Phospholipids and a phospholipid-rich diet alter the in vitro amyloid-beta peptide levels and amyloid-beta 42/40 ratios
-
Amtul, Z., M. Uhrig, R. Supino, and K. Beyreuther. 2010. Phospholipids and a phospholipid-rich diet alter the in vitro amyloid-beta peptide levels and amyloid-beta 42/40 ratios. Neurosci. Lett. 481: 73-77.
-
(2010)
Neurosci. Lett
, vol.481
, pp. 73-77
-
-
Amtul, Z.1
Uhrig, M.2
Supino, R.3
Beyreuther, K.4
-
43
-
-
84875534788
-
Effect of different phospholipids on alphasecretase activity in the non-amyloidogenic pathway of Alzheimer's disease
-
Grimm, M. O., V. J. Haupenthal, T. L. Rothhaar, V. C. Zimmer, S. Grosgen, B. Hundsdorfer, J. Lehmann, H. S. Grimm, and T. Hartmann. 2013. Effect of different phospholipids on alphasecretase activity in the non-amyloidogenic pathway of Alzheimer's disease. Int. J. Mol. Sci. 14: 5879-5898.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 5879-5898
-
-
Grimm, M.O.1
Haupenthal, V.J.2
Rothhaar, T.L.3
Zimmer, V.C.4
Grosgen, S.5
Hundsdorfer, B.6
Lehmann, J.7
Grimm, H.S.8
Hartmann, T.9
-
44
-
-
84856007240
-
Cdk5/p25-induced cytosolic PLA 2 -mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration
-
Sundaram, J. R., E. S. Chan, C. P. Poore, T. K. Pareek, W. F. Cheong, G. Shui, N. Tang, C. M. Low, M. R. Wenk, and S. Kesavapany. 2012. Cdk5/p25-induced cytosolic PLA 2 -mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration. J. Neurosci. 32: 1020-1034.
-
(2012)
J. Neurosci
, vol.32
, pp. 1020-1034
-
-
Sundaram, J.R.1
Chan, E.S.2
Poore, C.P.3
Pareek, T.K.4
Cheong, W.F.5
Shui, G.6
Tang, N.7
Low, C.M.8
Wenk, M.R.9
Kesavapany, S.10
-
45
-
-
84859511924
-
Critical role of cPLA 2 in Abeta oligomer-induced neurodegeneration and memory deficit
-
Desbène, C., C. Malaplate-Armand, I. Youssef, P. Garcia, C. Stenger, M. Sauvee, N. Fischer, D. Rimet, V. Koziel, M. C. Escanye, et al. 2012. Critical role of cPLA 2 in Abeta oligomer-induced neurodegeneration and memory deficit. Neurobiol. Aging. 33: 1123. e17-1129.e29.
-
(2012)
Neurobiol Aging
, vol.33
-
-
Desbène, C.1
Malaplate-Armand, C.2
Youssef, I.3
Garcia, P.4
Stenger, C.5
Sauvee, M.6
Fischer, N.7
Rimet, D.8
Koziel, V.9
Escanye, M.C.10
-
46
-
-
79960533372
-
Docosahexaenoic acid signalolipidomics in nutrition: Significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases
-
Bazan, N. G., M. F. Molina, and W. C. Gordon. 2011. Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu. Rev. Nutr. 31: 321-351.
-
(2011)
Annu. Rev. Nutr
, vol.31
, pp. 321-351
-
-
Bazan, N.G.1
Molina, M.F.2
Gordon, W.C.3
-
47
-
-
0034962977
-
Treatment of Alzheimer's disease
-
Cummings, J. L. 2001. Treatment of Alzheimer's disease. Clin. Cornerstone. 3: 27-39.
-
(2001)
Clin. Cornerstone
, vol.3
, pp. 27-39
-
-
Cummings, J.L.1
-
48
-
-
47549105901
-
Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: Current understanding and progress toward integrative prevention
-
Kidd, P. M. 2008. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention. Altern. Med. Rev. 13: 85-115.
-
(2008)
Altern. Med. Rev
, vol.13
, pp. 85-115
-
-
Kidd, P.M.1
-
49
-
-
84860402627
-
Lipid composition influences the release of Alzheimer's amyloid beta-peptide from membranes
-
Lemkul, J. A., and D. R. Bevan. 2011. Lipid composition influences the release of Alzheimer's amyloid beta-peptide from membranes. Protein Sci. 20: 1530-1545.
-
(2011)
Protein Sci
, vol.20
, pp. 1530-1545
-
-
Lemkul, J.A.1
Bevan, D.R.2
-
50
-
-
77951068851
-
Secretory phospholipase A 2 type III enhances alphasecretase- dependent amyloid precursor protein processing through alterations in membrane fluidity
-
Yang, X., W. Sheng, Y. He, J. Cui, M. A. Haidekker, G. Y. Sun, and J. C. Lee. 2010. Secretory phospholipase A 2 type III enhances alphasecretase- dependent amyloid precursor protein processing through alterations in membrane fluidity. J. Lipid Res. 51: 957-966.
-
(2010)
J. Lipid Res
, vol.51
, pp. 957-966
-
-
Yang, X.1
Sheng, W.2
He, Y.3
Cui, J.4
Haidekker, M.A.5
Sun, G.Y.6
Lee, J.C.7
-
51
-
-
83555163587
-
Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): Not just precursors of N-acyletha nolamines (NAE)
-
Coulon, D., L. Faure, M. Salmon, V. Wattelet, and J. J. Bessoule. 2012. Occurrence, biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just precursors of N-acyletha nolamines (NAE). Biochimie. 94: 75-85.
-
(2012)
Biochimie
, vol.94
, pp. 75-85
-
-
Coulon, D.1
Faure, L.2
Salmon, M.3
Wattelet, V.4
Bessoule, J.J.5
-
52
-
-
0033062508
-
Inhibitors of intracellular phospholipase A 2 activity: Their neurochemical effects and therapeutical importance for neurological disorders
-
Farooqui, A. A., M. L. Litsky, T. Farooqui, and L. A. Horrocks. 1999. Inhibitors of intracellular phospholipase A 2 activity: their neurochemical effects and therapeutical importance for neurological disorders. Brain Res. Bull. 49: 139-153.
-
(1999)
Brain Res. Bull
, vol.49
, pp. 139-153
-
-
Farooqui, A.A.1
Litsky, M.L.2
Farooqui, T.3
Horrocks, L.A.4
-
53
-
-
1642442420
-
Neuroprotection abilities of cytosolic phospholipase A 2 inhibitors in kainic acid-induced neurodegeneration
-
Farooqui, A. A., W. Y. Ong, and L. A. Horrocks. 2004. Neuroprotection abilities of cytosolic phospholipase A 2 inhibitors in kainic acid-induced neurodegeneration. Curr. Drug Targets Cardiovasc. Haematol. Disord. 4: 85-96.
-
(2004)
Curr. Drug Targets Cardiovasc. Haematol. Disord
, vol.4
, pp. 85-96
-
-
Farooqui, A.A.1
Ong, W.Y.2
Horrocks, L.A.3
|